Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotyping.
Journal Information
Full Title: EBioMedicine
Abbreviation: EBioMedicine
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Genetics, Medical
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"table 2 (raw data"
"Declaration of interests Several authors received funding as mentioned below. FB has received travel support by Novo Nordisk. Furthermore, he has a patent (PCT/EP2022/053142) for biomarkers for the diagnosis and treatment of endocrine hypertension, and methods of identification thereof. He also participated on an advisory board for Bayer (indication outside of the topic of the manuscript). All the other authors have no conflict of interest to report."
"This work is part of the German Cushing’s Registry CUSTODES and has been supported by a grant from the 10.13039/501100003042Else Kröner-Fresenius-Stiftung to M.R. (2012_A103 and 2015_A228). A.R., A.O., G.E., F.B., N.R. and M.R. are supported by the 10.13039/501100001659Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, Projektnummer: 314061271-TRR 205) and N.R. also by 10.13039/501100001659DFG 325768017 and F.B. by the Clinical Research Priority Program of the 10.13039/501100006447University of Zurich for the CRPP HYRENE. L.T.B. and H.F.N. are supported by the Clinician Scientist program RISE, founded by the 10.13039/501100003042Else Kröner-Fresenius-Stiftung and the Eva-Luise-und-Horst-Köhler-Stiftung (2019_KollegSE.03). The funding sources had no involvement in this study."
"This work is part of the German Cushing’s Registry CUSTODES and has been supported by a grant from the 10.13039/501100003042Else Kröner-Fresenius-Stiftung to M.R. (2012_A103 and 2015_A228). A.R., A.O., G.E., F.B., N.R. and M.R. are supported by the 10.13039/501100001659Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, Projektnummer: 314061271-TRR 205) and N.R. also by 10.13039/501100001659DFG 325768017 and F.B. by the Clinical Research Priority Program of the 10.13039/501100006447University of Zurich for the CRPP HYRENE. L.T.B. and H.F.N. are supported by the Clinician Scientist program RISE, founded by the 10.13039/501100003042Else Kröner-Fresenius-Stiftung and the Eva-Luise-und-Horst-Köhler-Stiftung (2019_KollegSE.03). The funding sources had no involvement in this study."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025